New software offers improved workflow efficiency with enhanced data management and the tools to support 21 CFR Part 11 compliance across the SCIEX mass spectrometry portfolio.

Improving the accuracy and user-friendliness of mass spec technologies to enable critical decisions in safety, healthcare and nutrition.

Mass spectrometry solutions for lab efficiency and productivity.

At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets.

The co-marketing agreement combines Shimadzu’s latest Q-TOF technology with Protein Metrics’ software, which automates biotherapeutic characterization workflows.

The Shimadzu LCMS-9030 is a research grade mass spectrometer designed to deliver high-resolution, accurate-mass detection with incredibly fast data acquisition rates, allowing scientists to identify and quantify more compounds with greater confidence.

Creating access to the power and potential of mass spectrometry for more laboratories.

Industry-leading adapters mitigate index hopping and spread of signal in
next gen sequencing applications.

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.